Kymera CSO Richard Chesworth to depart Oct 22; search underway

Kymera Therapeutics, Inc.

Richard Chesworth steps down as Chief Scientific Officer effective October 22, 2021.
Departure not related to any disagreements with company on operations, policies, or financial matters.
Company has initiated a search for a new chief scientific officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Chesworth

Chief Scientific Officer

KYMR · Kymera Therapeutics, Inc.

Effective: 2021-10-22
Filed: September 16, 2021, 7:59 PM ET

On September 16 th , 2021, Kymera Therapeutics, Inc. (the “Company”) announced that Richard Chesworth, its Chief Scientific Officer, will be departing the Company effective as of October 22 nd 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Chesworth departed as Chief Scientific Officer at Kymera Therapeutics, Inc..

Action: departing
Role: Chief Scientific Officer

Exact text from the filing

On September 16 th , 2021, Kymera Therapeutics, Inc. (the “Company”) announced that Richard Chesworth, its Chief Scientific Officer, will be departing the Company effective as of October 22 nd 2021.

View on SEC.gov

Kymera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-275102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.